U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead – Reuters

  1. U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead  Reuters
  2. High Court Rejects Bristol-Myers Unit’s $1.2 Billion Patent Case  Bloomberg Law
  3. Supreme Court rejects BMS bid to revive $1.2B patent fine  FiercePharma
  4. US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead – Gilead Scien  Benzinga
  5. View Full Coverage on Google News